Tickerplace logo

Tickerplace

Stoke Therapeutics, Inc. logo

STOKStoke Therapeutics, Inc.

STOK Stock Price, Valuation & Chart | Stoke Therapeutics, Inc.

Compare
$25.700+0.02 (+0.08%)

At close · 22 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

STOK Historical price chart

STOK Key Stats

Market Capitalization1.66B
PE Ratio-7.69
EPS-3.34
Trading Volume833.59K
Today's High/Low26.76/25.64
Dividend Yield0.00
52 Week High/Low40.22/20.32
Shares Outstanding64.53M
STOK Financial Statement
STOK Analyst ratings
STOK Analysis & performance metrics

STOK Company profile

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic…

STOK Management team

Management
Barry S. Ticho FACC, M.D., Ph.D.
Chief Medical Officer
Doug SnowCTO
Director of Communications & Investor Relations
Dawn Kalmar
Chief Communications Officer
Arthur O. Tzianabos Ph.D.
Interim Executive Chairman
Isabel Aznarez Ph.D.
Co-Founder, Head of Research & Senior Vice President
Jonathan Allan J.D.
Corporate Secretary & General Counsel
Ian F. Smith A.C.A., C.P.A.CEO
Interim Chief Executive Officer & Director
Adrian R. Krainer Ph.D.CTO
Co-Founder & Independent Director
Total 8 executives

STOK Frequently asked questions

What is Stoke Therapeutics, Inc. (STOK) Stock Price?

Current stock price of Stoke Therapeutics, Inc. (STOK) stock is $25.700. The stock price is +0.08% higher in the session. The intraday range can be seen from this page. Volume of Stoke Therapeutics, Inc. (STOK) stock is 833.59K.

Last updated at 22 Oct 2026, 08:00 pm.

Why is the Stoke Therapeutics, Inc. (STOK) stock price going up or down today?

The stock price of Stoke Therapeutics, Inc. (STOK) can change with earnings, company news, and overall market sentiment. Stoke Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Stoke Therapeutics, Inc. stock expensive at its current price?

Whether Stoke Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for STOK on this page is -7.69. EPS on this page is -3.34. Compare those figures with peers and growth expectations before deciding if the current Stoke Therapeutics, Inc. price is justified.

How has the stock price of Stoke Therapeutics, Inc. (STOK) performed historically?

Historical performance for Stoke Therapeutics, Inc. (STOK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how STOK reacted to past earnings and market events.

Should I buy Stoke Therapeutics, Inc. (STOK) stock, at this price?

Buying Stoke Therapeutics, Inc. (STOK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.